DaVita Says Ransomware Attack Affecting Some Operations

DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.

Dialysis firm DaVita hit by ransomware attack

DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach.

Here's why this Warren Buffett stock plunged 11% in a day

Shares of Davita Inc. (NYSE: DVA) plunged 11% on February 14, as the dialysis provider issued a weaker-than-expected 2025 earnings outlook, citing rising patient care costs, supply constraints, and...

Here's why Warren Buffett dumped $31 million worth of this stock

Warren Buffett, the ‘Oracle of Omaha', managed to attain a roughly $142 billion net worth by consistently outperforming the markets. The Berkshire Hathaway (NYSE: BRK.B) chief executive officer (CE...

Warren Buffett's Berkshire Hathaway sells some DaVita; Shares fall on disappointing guidance

DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares in a pre-planned agreement.

DaVita Inc. (DVA) Q4 2024 Earnings Call Transcript

DaVita Inc. (NYSE:DVA ) Q4 2024 Earnings Conference Call February 13, 2025 5:00 PM ET Company Participants Nic Eliason - Group VP, IR Javier Rodriguez - CEO Joel Ackerman - CFO Conference Call Part...

DaVita forecasts 2025 profit below estimates, shares plummet

Dialysis firm DaVita projected annual profit below estimates on Thursday due to rising patient care costs, sending its shares down 11% in after-hours trading.

4 Stocks Trading Near 52-Week High With Room to Rise Further

Investors target stocks that have been on a bullish run lately. Stocks like ENS, DVA, REVG and PAA are seeing price strength and the momentum is likely to continue.

Sell Nvidia, Buy This Stock

Big things happened this weekend.

DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider

DaVita HealthCare (DVA) closed at $169.90 in the latest trading session, marking a +0.86% move from the prior day.

Zacks Industry Outlook Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare

Quest Diagnostics, DaVita, Option Care Health and Addus HomeCare have been highlighted in this Industry Outlook article.

DaVita HealthCare (DVA) Ascends But Remains Behind Market: Some Facts to Note

The latest trading day saw DaVita HealthCare (DVA) settling at $162.36, representing a +0.22% change from its previous close.

DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts

DaVita HealthCare (DVA) closed the most recent trading day at $152.69, moving +0.77% from the previous trading session.

DaVita Stock Gains 40.1% Year to Date: What's Behind the Rally?

Strength in kidney care services and expansion into international markets raise optimism for DVA stock.

DaVita Inc. to Participate in UBS Global Healthcare Conference 2024

DENVER , Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will ...


Related Companies

Track Institutional and Insider Activities on DVA

Follow DAVITA INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVA shares.

Notify only if

Insider Trading

Get notified when an Davita Inc. insider buys or sells DVA shares.

Notify only if

News

Receive news related to DAVITA INC.

Track Activities on DVA